Inari Medical, Inc (NARI)

Etorro trading 970x250
Inari Medical, Inc (NARI) Logo

About Inari Medical, Inc

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California. Address: 9 Parker, Irvine, CA, United States, 92618

Inari Medical, Inc News and around…

Latest news about Inari Medical, Inc (NARI) common stock and company :

Chief Operating Officer Of Inari Medical Makes $790K Sale
21 Oct, 2021 Yahoo! Finance

Andrew Hykes, Chief Operating Officer at Inari Medical (NASDAQ:NARI), made a large insider sell on October 19, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Hykes sold 9,000 shares of Inari Medical at prices ranging from $85.47 to $89.16. The total transaction amounted to $789,878. Following the transaction, Hykes still owns 160,827 shares of Inari Medical worth $14,374,829. Inari Medical shares are trading d

Inari Medical Larger Than S&P 500 Component Discovery
20 Oct, 2021 FinancialContent

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Inari Medical Inc (NARI) was identified as having a larger market cap than the smaller end of the S&P 500, for example Discovery Inc (DISCA), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..

3 Under-the-Radar COVID Stocks
20 Oct, 2021 FinancialContent

Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients
18 Oct, 2021 Yahoo! Finance

IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced planned enrollment of the PEERLESS trial. PEERLESS is a new randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (“PE”) treated with the FlowTriever System versus catheter-directed thromboly

Hedge Funds Are Crazy About Inari Medical, Inc. (NARI)
18 Oct, 2021 Yahoo! Finance

In this article you are going to find out whether hedge funds think Inari Medical, Inc. (NASDAQ:NARI) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]

President And CEO Of Inari Medical Makes $2.4M Sale
08 Oct, 2021 FinancialContent

William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC ...

How Much Of Inari Medical, Inc. (NASDAQ:NARI) Do Insiders Own?
04 Oct, 2021 Yahoo! Finance

Every investor in Inari Medical, Inc. ( NASDAQ:NARI ) should be aware of the most powerful shareholder groups...

Reasons to Hold on to Inari Medical (NARI) Stock For Now
04 Oct, 2021 Yahoo! Finance

Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.

Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors
01 Oct, 2021 Yahoo! Finance

IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Mr. Dana G. Mead, Jr. to its board of directors. Mr. Mead will serve as a member of the Compensation Committee of the board. “We are pleased to welcome Dana as a new independent director to our board. Mr. Mead’s decades of executive ope

Chief Medical Officer Of Inari Medical Trades $416 Thousand In Company Stock
29 Sep, 2021 Yahoo! Finance

Thomas Tu, Chief Medical Officer at Inari Medical (NASDAQ:NARI), made a large buy and sell of company shares on September 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Thomas Tu exercised options to purchase 5,000 Inari Medical shares for $0 on September 27. They then sold their shares on the same day in the open market. They sold at prices ranging from $82.12 to $83.68 to raise a total of $414,311 from the stock sa

Should You Take the "Basket Approach" to Investing in Tech Stocks?
24 Sep, 2021 FinancialContent

When investing in big and growing industries, a group of stocks can be the best way to go.

Inari Medical Earnings Perspective: Return On Invested Capital
22 Sep, 2021 FinancialContent

Pulled from Benzinga Pro data, Inari Medical (NASDAQ:NARI) showed a loss in earnings since Q1, totaling $4.11 million. Sales, on the ...

Inari Medical Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs
21 Sep, 2021 FinancialContent
3 Top Healthcare Stocks You Can Buy for $100 or Less
16 Sep, 2021 FinancialContent

It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.

Inari Medical Insider Sold Over $567.17 Thousand In Company Stock
13 Sep, 2021 Yahoo! Finance

Donald B Milder, at Inari Medical (NASDAQ:NARI), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Milder sold 7,000 shares of Inari Medical at a price of $81.1 per share. The total transaction amounted to $567,167. Milder still owns a total of 4,787,817 of Inari Medical worth, $366,651,025. Inari Medical shares are trading down 3.72% at $76.58 at the time of this writing

3 Stocks That Could Soar 50% or Better, According to Wall Street
13 Sep, 2021 FinancialContent

All three of these growth stocks are poised to put up big gains once more investors land on the same page as investment bank analysts who follow them.

Why Is Inari Medical, Inc. (NARI) Up 8.8% Since Last Earnings Report?
09 Sep, 2021 Yahoo! Finance

Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 High-Growth Healthcare Stocks to Buy in September
09 Sep, 2021 FinancialContent

All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.

Inari Medical Insider Trades $2.45 Million In Company Stock
09 Sep, 2021 Yahoo! Finance

William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on September 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Hoffman sold 30,000 shares of Inari Medical at a price of $81.41 per share. The total transaction amounted to $2,447,099. Following the transaction, Hoffman still owns 700,831 shares of Inari Medical worth $57,285,925. Inari Medical shares were down at $81.

How The Parts Add Up: TUSA Headed For $54
08 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Total US Market AlphaDEX ETF (TUSA), we found that the implied analyst target price for the ETF based upon its underlying holdings is $54.18 per unit.

With EPS Growth And More, Inari Medical (NASDAQ:NARI) Is Interesting
03 Sep, 2021 Yahoo! Finance

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street
30 Aug, 2021 FinancialContent

There's a stock on this list analysts think can climb by around 47%, as soon as more investors come around to their way of seeing things.

Inari Medical to Present at Upcoming Investor Conferences
26 Aug, 2021 FinancialContent
Wall Street Thinks This Healthcare Stock Could Double Your Money in the Next Year
24 Aug, 2021 FinancialContent

Even the median estimate would be a 70% gain.

Here’s Why Baron Funds Remains Optimistic in Inari Medical (NARI)
18 Aug, 2021 Yahoo! Finance

Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. A return of 11.43% was delivered by the fund’s institutional shares for the Q2 of 2021, outperforming both its S&P 500 and Russell 3000 Health Care benchmarks that delivered […]

This Healthcare Company Just Shocked Its Investors
18 Aug, 2021 FinancialContent

The stock price is collapsing as a result.

66 Biggest Movers From Yesterday
12 Aug, 2021 FinancialContent

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last ...

Inari Medical Plunged 15% After Mixed Q2 Earnings, Lifting FY21 Sales Guidance
11 Aug, 2021 FinancialContent

Inari Medical Inc's(NASDAQ: NARI)Q2 revenue was $63.5 million, more than doubled from $25.4 million in Q2 FY20, ...

Dow, S&P 500 Extend Highs After CPI Reading
11 Aug, 2021 FinancialContent

The Dow and S&P 500 both nabbed intraday record highs today, the Nasdaq slipped lower.

12 Health Care Stocks Moving In Wednesday's Intraday Session
11 Aug, 2021 FinancialContent

Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. ...

Inari Medical, Inc (NARI) is a NASDAQ Common Stock listed in , ,

970x250